PQR620   Click here for help

GtoPdb Ligand ID: 10142

Synonyms: compound 3 [PMID: 30359003] | PQR-620
Compound class: Synthetic organic
Comment: PQR620 is a potent and selective inhibitor of mTORC1/2 mTOR-containing complexes that was developed by PIQUR Therapeutics [2]. It is brain-penetrating and is being analysed for clinical potential in neurological disorders and cancer. PQR620 was designed as a more effective alternative to the rapalogs sirolimus, everolimus and temsirolimus which show only modest overall response rates in solid tumours [1]. Chemically PQR620 is a rationally designed derivative of bimiralisib (PQR309), in which bimiralisib's trifluoromethyl group is substituted by a difluoromethyl group, and its morpholino groups are substituted with oxo-azabicyclo moieties.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 9
Hydrogen bond donors 1
Rotatable bonds 4
Topological polar surface area 102.52
Molecular weight 445.2
XLogP 2.66
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES Nc1ncc(c(c1)C(F)F)c1nc(nc(n1)N1C2COCC1CC2)N1C2COCC1CC2
Isomeric SMILES Nc1ncc(c(c1)C(F)F)c1nc(nc(n1)N1C2COCC1CC2)N1C2COCC1CC2
InChI InChI=1S/C21H25F2N7O2/c22-18(23)15-5-17(24)25-6-16(15)19-26-20(29-11-1-2-12(29)8-31-7-11)28-21(27-19)30-13-3-4-14(30)10-32-9-13/h5-6,11-14,18H,1-4,7-10H2,(H2,24,25)
InChI Key UGDKPWVVBKHRDK-UHFFFAOYSA-N
Bioactivity Comments
PQR620 exhibits favourable selectivity for mTOR over PI3K and other protein kinases [2]. It prevents proliferation in a screening panel of 66 cancer cell lines, and is anti-proliferative in a mouse xenograft model of ovarian cancer. Brain exposure is evidenced by PQR620's ability to reduce epileptic seizures in a tuberous sclerosis complex (TSC) mouse model.
Selectivity at enzymes
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
mechanistic target of rapamycin kinase Primary target of this compound Hs Inhibitor Inhibition 9.6 pKd - 2
pKd 9.6 (Kd 2.7x10-10 M) [2]
Description: Binding affinity constant.
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha Hs Inhibitor Inhibition 6.0 pKd - 2
pKd 6.0 (Kd 1x10-6 M) [2]
phosphatidylinositol 3-kinase catalytic subunit type 3 Hs Inhibitor Inhibition 5.6 pKd - 2
pKd 5.6 (Kd 2.75x10-6 M) [2]
mechanistic target of rapamycin kinase Hs Inhibitor Inhibition 8.0 pKi - 2
pKi 8.0 (Ki 1.08x10-8 M) [2]
Description: In vitro inhibition constant.
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha Hs Inhibitor Inhibition 5.4 pKi - 2
pKi 5.4 (Ki 4.203x10-6 M) [2]